Ubs Group Ag 180 Life Sciences Corp. Transaction History

Ubs Group Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$0.81 - $2.53 $1,376 - $4,298	1,699 New	1,699 $1,000
Q1 2022 May 16, 2022	SELL	$2.53 - $3.9 $45,590 - $70,278	-18,020 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.27 - $6.38 $58,925 - $114,967	18,020 New	18,020 $71,000
Q2 2021 Aug 13, 2021	SELL	$6.7 - $11.98 $7,785 - $13,920	-1,162 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$2.51 - $6.96 $2,916 - $8,087	1,162 New	1,162 $8,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $81.1M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.